Fei Yu

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 16

Top Venues

mBio

Biomolecules

Antibodies (Basel, Switzerland)

Viruses

Southern Medical University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Southern Medical University Sep 10 2010 - Jun 30 2014

China

PHD

Publications

Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (5) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (5) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retraction for Li et al., "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (4) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retraction for Li et al., "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (5) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retraction for Li et al., "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (4) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (5) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
Retracted and republished from: "The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs". mBio 15 (5) (2024)
Yanbai Li, Shanshan Huo, Zhe Yin, Zuguang Tian, Fang Huang, Peng Liu, Yue Liu, Fei Yu
The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs. mBio (2023)
Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, Fei Yu, Yuming Jiang, Le Zhang
A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis. Biomolecules 13 (1) (2022)
Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, Fei Yu, Yuming Jiang, Le Zhang
A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis. Biomolecules 13 (1) (2022)
Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, Fei Yu, Yuming Jiang, Le Zhang
A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis. Biomolecules 13 (1) (2022)
Ming Xiao, Fubo Ma, Jun Yu, Jianghang Xie, Qiaozhen Zhang, Peng Liu, Fei Yu, Yuming Jiang, Le Zhang
A Computer Simulation of SARS-CoV-2 Mutation Spectra for Empirical Data Characterization and Analysis. Biomolecules 13 (1) (2022)
Lili Wang, Jiyan Xu, Yu Kong, Ruiying Liang, Wei Li, Jinyao Li, Jun Lu, Dimiter S Dimitrov, Fei Yu, Yanling Wu, Tianlei Ying
Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV. Antibodies (Basel, Switzerland) 8 (4) (2019)
Ruiying Liang, Lili Wang, Naru Zhang, Xiaoqian Deng, Meng Su, Yudan Su, Lanfang Hu, Chen He, Tianlei Ying, Shibo Jiang, Fei Yu
Development of Small-Molecule MERS-CoV Inhibitors. Viruses 10 (12) (2018)

Fei Yu.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fei Yu